Introduction
Actin is the most abundant protein in most eukaryotic cells. The actin cytoskeleton is essential for diverse biological processes, including cell division, muscle contraction, cellular signaling, and motility. The dynamic assembly and disassembly of actin filaments from monomeric (G-actin) to filamentous (F-actin) is key to these processes. Dysfunction in actin dynamics is observed with age and is characteristic of various disease processes. Over the last several years, evidence has identified multiple roles for actin dynamics in neuronal aging and age-related neurodegenerative diseases such as Alzheimer’s. This newsletter highlights recent publications that have advanced our understanding of actin dynamics in neuronal aging.
Accumulation of F-actin promotes brain aging
Schmid et al. recently reported in a preprint that the accumulation of F-actin limits healthspan and promotes neuronal aging in Drosophila1, the first and most extensively used model for studying neuronal aging and neuronal diseases2. They determined that the mechanism underlying this phenomenon was diminished autophagy. Autophagy is a highly conserved and important recycling process for cellular components in all eukaryotic cells. This lysosome-dependent process is required for neuronal homeostasis – the degradation of dysfunctional neurons – and is impaired in the aging brain due to errors in actin dynamics1. The authors demonstrate that impeding actin filament polymerization promoted autophagy and slowed neuronal aging1. Conversely, stabilizing F-actin results in both disabled autophagy and mitophagy, a related recycling process that recycles damaged mitochondria.
Above: Schematic representation of actin filament dynamics, including actin depolymerizing factors on the top row, and F-actin promoting activities on the bottom row.
Actin cytoskeleton critical for neuronal membrane integrity
C-terminus of HSC70 Interacting Protein (CHIP), an E3-ubiquitin ligase, acts as a co-chaperone that regulates core chaperone machinery in protein folding, refolding, aggregation, and degradation processes3. Given its interaction with heat shock proteins like HSC70, CHIP is particularly important for protecting cells from thermal stress. CHIP has also been shown to be neuroprotective, but until recently, the mechanisms underlying this role were unknown. Dias et al. ablated CHIP in induced pluripotent stem cell (iPSC)-derived cortical neurons. They performed a proteomic analysis using Sequential Window Acquisition of all Theoretical Mass Spectra (SWATH-MS) and subsequent pathway analyses to determine proteomic changes between CHIP knockout and wild-type iPSCs that identified multiple membrane- and cytoskeletal-related proteins and pathways4, specifically, those involved in actin cytoskeleton signaling and membrane integrity networks. They then shared phenotypic data that confirmed differences in membrane and actin cytoskeletal homeostasis in the absence of CHIP function and that the absence of CHIP resulted in impaired membrane integrity and repair mechanisms4.
Compromised neuronal membranes are observed during physiological aging, acute traumatic brain injury, and neurodegenerative diseases5. The cell membrane is essential to any cell, maintaining distinct environments in the intra- and extracellular space, participating in signaling and cell-cell communication, and mediating cellular adhesion and motility. Cell membrane integrity is critical to neuronal function. Neurons have a highly polarized plasma membrane with distinct features6. The plasma membranes of the neuronal cell body and dendrites contain cell surface receptors that sense extracellular signaling molecules. Axonal membranes facilitate the transmission of nerve impulses and regulate myelination through glial signaling. Additionally, synaptic membranes are involved in the release and uptake of signaling molecules crucial for cellular communication. The actin cytoskeleton is critical for cell membrane integrity. The findings from Dias et al. suggest that the regulation of the actin cytoskeletal and membrane integrity explains the neuroprotective function of CHIP.
Actin filament reorganization in neuronal ischemic injury
In addition to physiological aging, actin dynamics play a role in neuronal injury and neurodegeneration. Ischemic stroke occurs due to a loss of oxygen and glucose supply that results from blocked cerebral blood vessels. The resulting neuronal damage is caused by a variety of biological processes. Neuronal swelling occurs quickly following a stroke due to ionic imbalance caused by an influx of ions through multiple entry routes, including cation entry through N-methyl-D-aspartate (NMDA) receptors and chloride entry through the SLC26A11 ion exchanger7. This ionic imbalance results in neuronal depolarization that spreads far beyond the site of initial injury.
Calabrese et al. revealed a role for altered actin dynamics in neuronal ischemic injury. In response to oxygen and glucose deprivation, cultured rat brain hippocampal neurons demonstrate actin reorganization in vitro. They further demonstrated that inducing stroke in mice caused neuronal actin reorganization8. Similarly, activation of NMDA receptors resulted in similar neuronal actin reorganization, suggesting that NMDA receptor activation was responsible for actin reorganization caused by stroke, specifically F-actin depolymerization within spines and polymerization into stable filaments within the dendrite shaft and soma8. Finally, they showed that this characteristic reorganization relied on F-actin polymerization factor inverted formin-2 (INF2)8.
Tau-driven F-actin stabilization in Alzheimer’s disease and related tauopathies
Alzheimer’s disease (AD) and other tauopathies are characterized by deposits of pathogenic tau isoforms in the brain. There remains disagreement about the driver of AD neurodegeneration, but decades of research have been conducted to understand the potential role of tau aggregates in disease pathology. One recently identified mechanism involves the tau-induced overstabilization of F-actin, which results in changes in nuclear and heterochromatin architecture, activation of retrotransposons, and neuronal cell cycle reentry9. The presence of pathogenic tau leads to elevated levels of moesin, a protein that anchors the cytoskeleton to the plasma membrane and an activator of the epithelial-to-mesenchymal transition (EMT). Moesin is important for establishing neuronal polarity in developing neurons9. In the context of cancer, moesin has been shown to cause overstabilization of F-actin10 while expression of transgenic human tau in otherwise healthy Drosophila was sufficient to upregulate moesin, and the brains of these Drosophila reveal several indicators of AD-like disease11.
Conclusion
Actin cytoskeletal dynamics are critical for healthy neuronal aging and are impaired in multiple neurological disorders. Specifically, stabilization of F-actin appears to be one risk factor for pathogenic neuronal aging in several contexts and could be a novel therapeutic target. Of course, the studies discussed in this newsletter largely utilize aging and disease models, and additional studies and clinical trials are needed to validate the translation of these findings to human conditions. However, there are growing indications that these findings can accurately apply to human pathologies. For instance, postmortem evaluations of brains from patients with AD reveal highly stable bundles of F-actin called Hirano bodies9,12. Further, transcriptomic analyses of human AD brains are consistent with the hypothesis that tau-induced actin stabilization, neurotoxicity, and cell cycle activation depend on moesin11. Additionally, histological specimens of human AD brains revealed that moesin was localized with disease-associated phosphotau and F-actin11.
References
1. Schmid ET, Schinaman JM, Williams KS, Walker DW. Accumulation of F-actin drives brain aging and limits healthspan in Drosophila. Res Sq. 2023.
2. Víctor López del Amo AT, Máximo Ibo Galindo. Chapter 43 - Drosophila models of neuronal aging,. In: Colin R. Martin VRP, Rajkumar Rajendram, editor. Assessments, Treatments and Modeling in Aging and Neurological Disease. The Neuroscience of Aging: Academic Press; 2021. p. 481-90.
3. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J, et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol. 2001;3(1):93-6.
4. Dias C, Nita E, Faktor J, Tynan AC, Hernychova L, Vojtesek B, et al. CHIP-dependent regulation of the actin cytoskeleton is linked to neuronal cell membrane integrity. iScience. 2021;24(8):102878.
5. Dias C, Nylandsted J. Plasma membrane integrity in health and disease: significance and therapeutic potential. Cell Discov. 2021;7(1):4.
6. Sural-Fehr T, Bongarzone ER. How membrane dysfunction influences neuronal survival pathways in sphingolipid storage disorders. J Neurosci Res. 2016;94(11):1042-8.
7. Rungta RL, Choi HB, Tyson JR, Malik A, Dissing-Olesen L, Lin PJC, et al. The cellular mechanisms of neuronal swelling underlying cytotoxic edema. Cell. 2015;161(3):610-21.
8. Calabrese B, Jones SL, Shiraishi-Yamaguchi Y, Lingelbach M, Manor U, Svitkina TM, et al. INF2-mediated actin filament reorganization confers intrinsic resilience to neuronal ischemic injury. Nat Commun. 2022;13(1):6037.
9. Frost B. Alzheimer's disease and related tauopathies: disorders of disrupted neuronal identity. Trends Neurosci. 2023;46(10):797-813.
10. Clucas J, Valderrama F. ERM proteins in cancer progression. J Cell Sci. 2014;127(Pt 2):267-75.
11. Beckmann A, Ramirez P, Gamez M, Gonzalez E, De Mange J, Bieniek KF, et al. Moesin is an effector of tau-induced actin overstabilization, cell cycle activation, and neurotoxicity in Alzheimer's disease. iScience. 2023;26(3):106152.
12. Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT, et al. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol. 2007;9(2):139-48.